NEW YORK (GenomeWeb) – Premaitha Health announced today that it has signed an agreement with Ampath group to offer Premaitha’s Iona test in South Africa, where the UK firm has selected Barker Medical as its distributor.

Premaitha's Iona noninvasive prenatal test predicts a fetus' risk of having genetic conditions such as Down's syndrome. Clinicians perform the test on a maternal blood sample, which contains traces of fetal DNA, and analyze the sample using next-generation DNA sequencing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.